<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on March 04, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05104619</url>
  </required_header>
  <id_info>
    <org_study_id>s PI2020_843_0156</org_study_id>
    <nct_id>NCT05104619</nct_id>
  </id_info>
  <brief_title>Spectroscopic Analysis of Tongue Tumor Samples.</brief_title>
  <acronym>SpecTum</acronym>
  <official_title>Prospective Analysis of Tumor Tissues From the Oral Cavity by SpiderMassTM Spectroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Université de Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In squamous cell carcinoma of the tongue, complete surgical resection of the tumor generally&#xD;
      represents the primary treatment strategy. Among factors determining the disease prognostic,&#xD;
      the surgical margins status is essential for the continued management of the patient, with or&#xD;
      without complementary therapies. Generally, surgical margins are defined using visual and&#xD;
      tactile elements. Unfortunately, in 15 to 30 percent of cases, they are defined as positive&#xD;
      after histopathological examination, on average 5 to 7 days post-surgery.&#xD;
&#xD;
      Techniques have recently been developed to analyze the cancerous and non-cancerous nature of&#xD;
      tissues, using the spectral properties of tumor cells. SpiderMass™ is an instrument equipped&#xD;
      with a probe for tissue micro-sampling and real-time molecular profile analysis. It is thus&#xD;
      ultimately a tool for anatomopathological decision support, for diagnosis and prognosis of&#xD;
      the disease. Used in the operating room, SpiderMass™ could also become an innovative surgical&#xD;
      tool to precisely define cancerous areas in situ and the margins status in intraoperative&#xD;
      conditions.&#xD;
&#xD;
      Based on the principle of artificial intelligence, the SpiderMass™ machine must initially&#xD;
      learn to recognize pathological tissues versus healthy. This project aims to accomplish this&#xD;
      first phase of machine learning for squamous cell carcinoma of the tongue.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tumor cells detection in tongue tumor with SpiderMass technique</measure>
    <time_frame>1 year</time_frame>
    <description>Tumor cells detection in tongue tumor with SpiderMass technique</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">14</enrollment>
  <condition>Mass Spectroscopy</condition>
  <condition>Molecular Profile</condition>
  <condition>Surgical Margins</condition>
  <condition>Squamous Cell Carcinoma</condition>
  <condition>Oral Cavity</condition>
  <condition>Tongue</condition>
  <arm_group>
    <arm_group_label>tumor samples</arm_group_label>
    <description>(SCC of the tongue)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy tissues</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tongue surgery</intervention_name>
    <description>In squamous cell carcinoma of the tongue, complete surgical resection of the tumor</description>
    <arm_group_label>healthy tissues</arm_group_label>
    <arm_group_label>tumor samples</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tissue samples will be taken from the tumor and the non-tumor areas. Surgical specimens will&#xD;
      be taken in a fresh state immediately after surgery, by an anatomopathologist and a&#xD;
      pathological anatomy technician. The sample will be analyzed under standard conditions. Two&#xD;
      sites will be selected macroscopically (including a tumor area, a dysplasia area, and a&#xD;
      non-tumor area).&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated in the Maxillofacial Surgery Department of the CHU Amiens-Picardie for a&#xD;
        squamous cell carcinoma of the tongue and for whom the first-line treatment is surgical&#xD;
        resection&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age : 18 years and older&#xD;
&#xD;
          -  squamous cell carcinoma of the tongue&#xD;
&#xD;
          -  surgical resection as first-line treatment&#xD;
&#xD;
          -  tumor classification T1 to T4.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  metastatic disease&#xD;
&#xD;
          -  neoadjuvant therapies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christophe ATTENCOURT, MD</last_name>
    <phone>03 22 66 87 66</phone>
    <email>attencourt.christophe@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Amiens</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe ATTENCOURT, MD</last_name>
      <phone>03 22 66 87 66</phone>
      <email>attencourt.christophe@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 12, 2021</study_first_submitted>
  <study_first_submitted_qc>November 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mass spectroscopy</keyword>
  <keyword>molecular profile</keyword>
  <keyword>surgical margins</keyword>
  <keyword>squamous cell carcinoma</keyword>
  <keyword>oral cavity</keyword>
  <keyword>tongue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

